• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES SAPIEN 3 ULTRA RESILIA TRANSCATHETER HEART VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES SAPIEN 3 ULTRA RESILIA TRANSCATHETER HEART VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 9755RSL20A
Medical Device Problem Codes Incomplete Coaptation (2507); Intravalvular regurgitation (4068)
Health Effect - Clinical Code Insufficient Information (4580)
Date of Event 08/11/2025
Type of Reportable Event Serious Injury
Event or Problem Description
As reported by the field clinical specialist (fcs), during a transfemoral tpvr procedure with a 20mm sapien 3 ultra resilia valve, the valve was successfully implanted, and the team wanted to post dilate the valve.The team inflated the 20mm atlas to 12-14atm twice, and post angiogram showed central pulmonary regurgitation possibly due to a stuck leaflet.The team was able to confirm that 2 of the leaflets were functioning appropriately.The operator attempted to use a pigtail to dislodge the stuck leaflet but was unsuccessful.It was then determined to place a second 20mm sapien 3 ultra resilia valve.The patient underwent a valve in valve procedure.There was no pulmonary regurgitation was seen.
 
Additional Manufacturer Narrative
Investigation is still ongoing.
 
Additional Manufacturer Narrative
This supplemental report is being submitted as the event was found to be a duplicate of manufacturing report number 2015691-2025-07231.The event investigation, device evaluation, and applicable reporting activities will be performed under manufacturing report number 2015691-2025-07231.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SAPIEN 3 ULTRA RESILIA TRANSCATHETER HEART VALVE
Common Device Name
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
renee van dorne
1 edwards way
irvine, CA 92614
9492506385
MDR Report Key22982464
Report Number2015691-2025-07311
Device Sequence Number15687885
Product Code NPT
UDI-Device Identifier00690103215793
UDI-Public(01)00690103215793(17)260830(11)230831
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,User Facility,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 09/11/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date08/30/2026
Device Model Number9755RSL20A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/11/2025
Supplement Date Received by Manufacturer08/16/2025
Initial Report FDA Received Date09/05/2025
Supplement Report FDA Received Date09/11/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured08/31/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-